Development of Monoclonal Antibodies in China: Overview and Prospects

الملخص EN

Monoclonal antibodies (mAbs) have become increasingly important as human therapeutic agents.

Yet, current research concentrates on technology itself and pays attention to developed countries.

This paper aims to provide a comprehensive review of mAbs development in China through systematic analysis of drug registry, patent applications, clinical trials, academic publication, and ongoing R&D projects.

The trends in therapeutic areas and industrialization process are also highlighted.

Development and research trends of mAbs are analyzed to provide a future perspective of mAbs as therapeutic agents in China.